CoChat

Domperidone: Limited Benefits With Significant Risk for Sudden Cardiac Death

Hondeghem, Luc M. · 2013 · Journal of Cardiovascular Pharmacology
Cited by 53

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Domperidone (antinausea/vomiting agent) was recently shown by several groups to increase sudden cardiac death (SCD). Drug-induced disturbances of cardiac repolarization may be a major mechanism. METHODS AND RESULTS: Experiments were executed in isolated female rabbit hearts perfused for 150 minutes with domperidone 30, 60, or 100 nM. Domperidone significantly prolonged the action potential duration: +9% at 30 nM, +32% at 60 nM, and +48% at 100 nM. Domperidone induced significant disturbances of repolarization in 83% of hearts at 60 nM and in 100% at 100 nM, including early afterdepolarizations and polymorphic ventricular tachycardia. Maximum therapeutic free drug plasma concentration of domperidone (19 nM) yields a safety index of only ∼2.5, that is, 12-fold below the accepted minimum. Gastrointestinal benefits and risks for SCD were derived from the literature. The defined daily dose of domperidone (30 mg/day) fails to show unequivocal gastrointestinal benefits beyond a placebo effect. In contrast, 5 of 5 population-based studies show that oral domperidone significantly increases the odds ratio for SCD to 2.8 (1.53-6.21) and it increases sharply above 30 mg/day. CONCLUSIONS: Because domperidone has placebo-like benefits but is associated with increased SCD and a narrow safety margin, it should not be used in medicine.

Overview

Integrity signals

Registry

Crossref · 10.1097/fjc.0b013e31827afd0d

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Research works printed but not linked: 38

  1. Reddymasu, 2007, Am J Gastroenterol, 102, 2036, 10.1111/j.1572-0241.2007.01255.x · DOI · Paper page
  2. Straus, 2005, Eur Heart J, 26, 2007, 10.1093/eurheartj/ehi312 · DOI · Paper page
  3. De Bruin, 2006, Br J Clin Pharmacol, 63, 216, 10.1111/j.1365-2125.2006.02722.x · DOI · Paper page
  4. Hennessy, 2008, Pharmacoepidemiol Drug Saf, 17, 1131, 10.1002/pds.1632 · DOI
  5. van Noord, 2010, Drug Saf, 33, 1003, 10.2165/11536840-000000000-00000 · DOI
  6. Johannes, 2010, Pharmacoepidemiol Drug Saf, 19, 881, 10.1002/pds.2016 · DOI · Paper page
  7. Giaccone, 1984, Lancet, 2, 1336, 10.1016/S0140-6736(84)90841-9 · DOI
  8. Joss, 1982, Lancet, 1, 1019, 10.1016/S0140-6736(82)92016-5 · doi:10.1016/s0140-6736(82)92016-5
  9. Roussak, 1984, Br Med J, 289, 1579, 10.1136/bmj.289.6458.1579 · DOI · Paper page
  10. Osborne, 1985, Lancet, 2, 385, 10.1016/S0140-6736(85)92515-2 · DOI
  11. Bruera, 1986, Cancer Treat Rep, 70, 545
  12. Osborne, 1985, Hum Toxicol, 4, 617, 10.1177/096032718500400608 · doi:10.1177/096032718500400608
  13. Rossi, 2010, Curr Drug Saf, 5, 257, 10.2174/157488610791698334 · DOI · Paper page
  14. Drolet, 2000, Circulation, 102, 1883, 10.1161/01.CIR.102.16.1883 · DOI · Paper page
  15. Hondeghem, 2011, Acta Cardiol, 6, 421, 10.1080/AC.66.4.2126588 · DOI
  16. Hondeghem, 2003, J Cardiovasc Electrophysiol, 14, 287, 10.1046/j.1540-8167.2003.02466.x · DOI
  17. Hondeghem, 2001, Circulation, 103, 2004, 10.1161/01.CIR.103.15.2004 · DOI · Paper page
  18. Claassen, 2005, Pharmacology, 74, 31, 10.1159/000083234 · DOI · Paper page
  19. Redfern, 2003, Cardiovasc Res, 58, 32, 10.1016/S0008-6363(02)00846-5 · DOI · Paper page
  20. Hondeghem, 2008, Eur J Pharmacol, 584, 1, 10.1016/j.ejphar.2008.01.016 · DOI
  21. Hondeghem, 1994, J Cardiovasc Electrophysiol, 5, 711, 10.1111/j.1540-8167.1994.tb01193.x · doi:10.1111/j.1540-8167.1994.tb01193.x
  22. Itoh, 2005, Biol Pharm Bull, 28, 1752, 10.1248/bpb.28.1752 · DOI
  23. Hondeghem, 2011, J Cardiovasc Pharmacol, 57, 589, 10.1097/FJC.0b013e3182135e91 · DOI
  24. Pritchard, 2005, Br J Clin Pharmacol, 59, 725, 10.1111/j.1365-2125.2005.02422.x · doi:10.1111/j.1365-2125.2005.02422.x
  25. Tighe, 2009, Paediatr Drugs, 11, 185, 10.2165/00148581-200911030-00004 · doi:10.2165/00148581-200911030-00004
  26. Lewis, 1926, Heart, 13, 95
  27. Shah, 2005, Heart Rhythm, 2, 758, 10.1016/j.hrthm.2005.03.023 · DOI · Paper page
  28. Maddern, 1986, J Clin Gastroenterol, 8, 135, 10.1097/00004836-198604000-00006 · DOI
  29. Sakamoto, 2011, Hepatogastroenterology, 58, 637
  30. Markey, 2012, Ir J Med Sci, 181, 215, 10.1007/s11845-011-0785-2 · DOI
  31. Prakash, 1998, Drugs, 56, 429, 10.2165/00003495-199856030-00011 · DOI
  32. Takahashi, 1991, Gastroenterology, 101, 703, 10.1016/0016-5085(91)90528-S · DOI
  33. Braun, 1989, Adv Ther, 6, 51
  34. Lu, 2001, J Cardiovasc Electrophysiol, 12, 93, 10.1046/j.1540-8167.2001.00093.x · DOI · Paper page
  35. Ward, 2004, Br J Pharmacol, 58, 277, 10.1111/j.1365-2125.2004.02156.x · DOI · Paper page
  36. Couture, 2006, Pharmacol Rev, 58, 244, 10.1124/pr.58.2.7 · DOI
  37. Reiche, 2011, J Pharm Sci, 100, 2469, 10.1002/jps.22437 · DOI
  38. De Ponti, 2002, Br J Clin Pharmacol, 54, 171, 10.1046/j.1365-2125.2002.01617.x · DOI · Paper page

Cited by

See all 53

Metadata

Authors
Hondeghem, L. M.
Venue
Journal of Cardiovascular Pharmacology
Published
2013-03
Volume
61
Issue
3
Pages
218-225
ISSN
0160-2446
Cited by
53
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Domperidone: Limited Benefits With Significant Risk for Sudden Cardiac Death. https://app.cochat.ai/papers/10.1097/fjc.0b013e31827afd0d
The paper
Hondeghem, L. M. (2013). Domperidone: Limited Benefits With Significant Risk for Sudden Cardiac Death. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/fjc.0b013e31827afd0d

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.